184 related articles for article (PubMed ID: 999252)
21. Studies on flufenamic acid capsules and tablets.
Akbuğa J; Gülhan S; Bayraktar-Alpmen G
Pharmazie; 1983 Jul; 38(7):478-80. PubMed ID: 6634915
[TBL] [Abstract][Full Text] [Related]
22. [Doxycycline bioavailability in capsules].
Berezovskaia LN; Koroleva VG; Granatova EK; Grakovskaia LK
Antibiotiki; 1979 Nov; 24(11):821-4. PubMed ID: 389153
[TBL] [Abstract][Full Text] [Related]
23. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y
Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
[TBL] [Abstract][Full Text] [Related]
24. The bioavailability of flufenamic acid and its dissolution rate from capsules.
Kaniwa N; Ogata H; Aoyagi N; Shibazaki T; Ejima A; Watanabe Y; Motohashi K; Sasahara K; Nakajima E; Morioka T; Nitanai T
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):56-63. PubMed ID: 6840926
[TBL] [Abstract][Full Text] [Related]
25. Comparison of operational characteristics of different dissolution testing systems.
Hardwidge EA; Sarapu AC; Laughlin WC
J Pharm Sci; 1978 Dec; 67(12):1732-5. PubMed ID: 722490
[TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical availability of papaverine hydrochloride from spray-dried products prepared with cellulose phthalates.
Senjković R; Bećirević M; Rudić J
Pharmazie; 1990 Oct; 45(10):749-51. PubMed ID: 2089385
[TBL] [Abstract][Full Text] [Related]
27. Comparative dissolution rate studies of commercial furosemide tablets.
Gadalla MA; Ismail AA
Pharmazie; 1981 Aug; 36(8):553-6. PubMed ID: 7291288
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
29. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets.
Ammar HO; Khalil RM; Omar SM
Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438
[TBL] [Abstract][Full Text] [Related]
30. [Properties and stability of tetracycline hydrochloride tablets].
Nesterova LIa; Donskaia NG; Shadyro LL; Grakovskaia LK
Antibiotiki; 1978 Jan; 23(1):62-6. PubMed ID: 623449
[TBL] [Abstract][Full Text] [Related]
31. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. part 6: rifampicin.
Ammar HO; Khalil RM
Pharmazie; 1996 Mar; 51(3):165-8. PubMed ID: 8900866
[TBL] [Abstract][Full Text] [Related]
32. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
Strauch S; Jantratid E; Dressman JB
J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
[TBL] [Abstract][Full Text] [Related]
33. Proceedings: A study of the in vitro dissolution behaviour of different brands of sulphathiazole tablets and tetracycline hydrochloride capsules.
York P
West Afr J Pharmacol Drug Res; 1974 Dec; 2(1):91P. PubMed ID: 4470659
[No Abstract] [Full Text] [Related]
34. [The bioavailability of nifedipine in different solid pharmaceutical preparations for oral use].
Leucuta SE; Vida-Simiti L; Mocan A; Făgărăşan E; Bugnariu S; Baloescu C; Olinic N; Vlaicu R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):521-8. PubMed ID: 2577014
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
Koch HP; Alcorn G; Ritschel WA
Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
[TBL] [Abstract][Full Text] [Related]
36. Dissolution of metronidazole from oral and vaginal dosage forms in sink and non-sink conditions.
Bećirević M; Kallay N; Senjković R
Pharmazie; 1988 Aug; 43(8):544-6. PubMed ID: 3237744
[TBL] [Abstract][Full Text] [Related]
37. Discrepancy among dissolution rates of commercial tables as a function of the dissolution method. Part 7: Aspirin.
Ammar HA; el-Nahhas SA; Emara LH; Ghorab MM; Salama HA
Pharmazie; 1997 Feb; 52(2):145-9. PubMed ID: 9122273
[TBL] [Abstract][Full Text] [Related]
38. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
39. The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets.
Johnson BF; Greer H; McCrerie JA; Bye C; Fowle AS
Postgrad Med J; 1974 Nov; 50 Suppl 6():48-52. PubMed ID: 4617868
[No Abstract] [Full Text] [Related]
40. Dissolution evaluation of marketed tetracyclines solid oral dosage forms.
Yamamoto CH; Pinto Tde J; Alves MS
Boll Chim Farm; 2000; 139(2):81-4. PubMed ID: 10920533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
